- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 20.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 20.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 19.22M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $54K |
| Capex | Q1 2026 · Mar 31, 2025 | $392K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.82M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.69M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $7.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $13.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $6.25M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.89M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.79M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.01M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.94M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.39M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.15M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.03M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.45M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.22M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.56M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.57M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.09M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $659K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.34M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $229K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $432K |